Sheldon Litwin to Survival Analysis
This is a "connection" page, showing publications Sheldon Litwin has written about Survival Analysis.
Connection Strength
0.119
-
Diagnosing coronary artery disease in women: an update on cardiac imaging modalities. Obstet Gynecol. 2010 Jan; 115(1):156-169.
Score: 0.072
-
High prevalence of right ventricular dysfunction in ICD patients with shocks: a potential new predictor in risk stratification. J Interv Card Electrophysiol. 2011 Aug; 31(2):165-9.
Score: 0.020
-
Phase II study of N-phosphonacetyl-L-aspartate, recombinant interferon-alpha, and fluorouracil infusion in advanced squamous cell carcinoma of the head and neck. Head Neck. 1998 Aug; 20(5):385-91.
Score: 0.008
-
Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation. Cancer J Sci Am. 1996 Mar-Apr; 2(2):99-105.
Score: 0.007
-
Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation. 1994 Sep; 90(3):1410-22.
Score: 0.006
-
Report of phase II trial of concurrent chemoradiotherapy with radical thoracic irradiation (60 Gy), infusional fluorouracil, bolus cisplatin and etoposide for clinical stage IIIB and bulky IIIA non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 1993 Jun 15; 26(3):469-78.
Score: 0.006